Ownership

Andrew D. Dickinson - Chief Financial Officer at Gilead Sciences, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Financial Officer
Stock Symbol: GILD on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

Andrew D. Dickinson - trading volume in the past year for Gilead Sciences, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-10K	100%	$82.89	-$829K
Net	-10K	-100%		-$829K

Holdings reported by Andrew D. Dickinson for Gilead Sciences, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	139K	$11.3M	$81.44	Sep 10, 2024	Direct
Non-qualified Stock Option (Right to Buy)	88K	$6.99M	$79.45	Mar 10, 2024	Direct	Common Stock
Restricted Stock Unit	39.1K	$3.05M	$78.03	Sep 10, 2024	Direct	Common Stock
Restricted Stock Unit	42.8K	$2.79M	$65.25	Jun 10, 2024	Direct	Common Stock

Transactions reported by Andrew D. Dickinson for Gilead Sciences, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.